Loading clinical trials...
Loading clinical trials...
The goal of this study is to evaluate the safety and tolerability of TG-C in subjects with chronic discogenic lumbar back pain due to degenerative disc disease. Participants will be administered a sin...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Kolon TissueGene, Inc.
NCT07127380 · Lower Back Pain Chronic, Lumbar Degenerative Disease, and more
NCT07254806 · Degenerative Disc Disease
NCT05508360 · Degenerative Disc Disease, Chronic Low-back Pain
NCT05037968 · Degenerative Disc Disease, Spine Fusion, and more
NCT05029726 · Lumbar Spinal Stenosis, Lumbar Disc Herniation, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions